While the level of MK2 expression did not correlate with the tumor grade, patient age or gender, MK2 was strongly expressed in secondary (p = 0.009; chi-square test) and IDH1-positive (p = 0.013; chi-square test) glioblastomas (Supplementary Figure S1C). Here, MAPKAPK2 is linked to glioblastoma.